Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast

Beyond Air (NASDAQ: XAIR) will report third fiscal quarter 2026 financial results for the period ended December 31, 2025 on Friday, February 13, 2026.

Rhea-AI Summary

Beyond Air (NASDAQ: XAIR) will report third fiscal quarter 2026 financial results for the period ended December 31, 2025 on Friday, February 13, 2026. Management will host a conference call and webcast at 8:00 AM Eastern Time the same day. Investors can join by dialing the domestic number 1-877-407-0784 or the international number 1-201-689-8560 using Conference ID 13758405. A live webcast will be available via the company’s Events page, and an online replay will be posted about one hour after the call.

Argus Jan 27 session

-7.53% close to close Open Argus

Details

News Market Reaction – XAIR

In the Jan 27 session, XAIR declined 7.53%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -7.5% in the session following this news. A negative reaction despite this being a r...

Analysis

The stock moved -7.5% in the session following this news. A negative reaction despite this being a routine scheduling announcement would fit a pattern where funding needs and past dilution weigh on sentiment. Recent disclosures highlighted ongoing net losses and reliance on external financing, which could heighten sensitivity ahead of Q3 FY2026 results. Weakness following such neutral news might reflect caution about upcoming financials rather than the call notice itself.

Key Figures

Earnings call date: February 13, 2026 Call time: 8:00 AM ET Domestic dial-in: 1-877-407-0784 +5 more

Earnings call date

February 13, 2026

Q3 FY2026 results for quarter ended December 31, 2025

Call time

8:00 AM ET

Third fiscal quarter 2026 conference call

Domestic dial-in

1-877-407-0784

Access number for earnings call

Q2 FY2026 revenue

$1.8 million

Quarter ended September 30, 2025 (10-Q)

Prior-year revenue

$0.8 million

Q2 prior year comparison (10-Q)

Net loss

$8.3 million

Q2 FY2026 net loss; EPS <b>$1.25</b> (10-Q)

Cash & equivalents

$10.9 million

Balance as of September 30, 2025 (10-Q)

Long-term debt

$10.1 million

Long-term debt, net, as of September 30, 2025 (10-Q)

Previous Conferences,earnings Reports

5 past events · Latest: Oct 23

Same Type 5 events

1. Oct 23

   Earnings call scheduling

   24h Move

   +4.0%

   Announced Q2 FY2026 results release and 4:30 PM ET conference call details.

2. Jul 25

   Earnings call scheduling

   24h Move

   -3.6%

   Set date and time for Q1 FY2026 financial results call and webcast.

3. May 20

   Earnings call scheduling

   24h Move

   +1.5%

   Announced fiscal Q4 and full-year 2025 results release and investor call.

4. Jan 27

   Earnings call scheduling

   24h Move

   -1.8%

   Scheduled fiscal Q3 2025 results release and 4:30 PM ET conference call.

5. Oct 29

   Earnings call scheduling

   24h Move

   +8.8%

   Set timing for fiscal Q2 2025 earnings release and related investor webcast.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

nitric oxide, webcast

2 terms

nitric oxide medical

"focused on harnessing the power of nitric oxide (NO) to improve the lives"

A simple signaling molecule made of one nitrogen and one oxygen atom that acts like a tiny messenger in the body, telling blood vessels to widen, controlling breathing and influencing immune responses. Investors care because products that deliver, mimic, or measure this gas—such as inhaled therapies, drugs that boost its effects, or diagnostic tests—can affect patient outcomes, regulatory approvals and market value; think of it as a traffic controller for blood and air flow whose tools can become investable medical products.

webcast technical

"conference call and webcast at 8:00 am Eastern Time the same day"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GARDEN CITY, N.Y., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that it will report financial results for its third fiscal quarter ended December 31, 2025 on Friday, February 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 am Eastern Time the same day.

Conference Call & Webcast
Friday, February 13th@ 8:00 AM ET
Domestic:	1-877-407-0784
International:	1-201-689-8560
Conference ID:	13758405
Webcast:	A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call.

About Beyond Air, Inc.
Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. Beyond Air is currently advancing its other revolutionary LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria (NTM).

Additionally, Beyond Cancer, Ltd., an affiliate of Beyond Air, is investigating ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumors in the pre-clinical setting. For more information, visit www.beyondair.net.

CONTACTS:

Corey Davis, Ph.D.
LifeSci Advisors, LLC
Cdavis@lifesciadvisors.com
(212) 915-2577

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Beyond Air (XAIR) report Q3 fiscal 2026 results?

Beyond Air will report results for the quarter ended December 31, 2025 on Friday, February 13, 2026.

What time is the Beyond Air (XAIR) Q3 2026 conference call and webcast?

The management conference call and webcast is scheduled for 8:00 AM Eastern Time on February 13, 2026.

How do I join the Beyond Air (XAIR) conference call by phone?

Dial 1-877-407-0784 (domestic) or 1-201-689-8560 (international) and enter Conference ID 13758405.

Where can I access the Beyond Air (XAIR) live webcast and replay?

Access the live webcast via the company’s Events page; an online replay will be posted about one hour after the call.

Will Beyond Air (XAIR) provide a replay of the Q3 2026 earnings call?

Yes, an online replay will be available on the company website or via the direct webcast link roughly one hour after the live call.

What is the conference ID for Beyond Air (XAIR) Q3 2026 earnings call?

Use Conference ID 13758405 when joining the phone conference.